| 20.8182 1.158 (5.89%) | 09-14 13:22 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 27.02 | 1-year : | 29.72 |
| Resists | First : | 23.13 | Second : | 25.45 |
| Pivot price | 22.77  |
|||
| Supports | First : | 19.38 | Second : | 16.13 |
| MAs | MA(5) : | 21.17 |
MA(20) : | 23.05 |
| MA(100) : | 19.84 |
MA(250) : | 18.22 |
|
| MACD | MACD : | -0.4 |
Signal : | 0 |
| %K %D | K(14,3) : | 12.8 |
D(3) : | 8 |
| RSI | RSI(14): 42.4 |
|||
| 52-week | High : | 26.91 | Low : | 10.27 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ OMDA ] has closed above bottom band by 17.9%. Bollinger Bands are 22.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 21.76 - 21.86 | 21.86 - 21.97 |
| Low: | 19.1 - 19.23 | 19.23 - 19.35 |
| Close: | 19.43 - 19.63 | 19.63 - 19.82 |
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Thu, 10 Sep 2026
Omada Health (NASDAQ: OMDA) officer lines up new stock sale after plan trades - Stock Titan
Thu, 10 Sep 2026
Omada Health (OMDA) holder plans sale after RSU vesting - Stock Titan
Thu, 10 Sep 2026
Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day - The Manila Times
Thu, 10 Sep 2026
Members and revenue nearly tripled at Omada Health - Stock Titan
Wed, 09 Sep 2026
Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares - The Motley Fool
Wed, 09 Sep 2026
Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares - Currently.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 61 (M) |
| Shares Float | 51 (M) |
| Held by Insiders | 2.1 (%) |
| Held by Institutions | 86.6 (%) |
| Shares Short | 5,890 (K) |
| Shares Short P.Month | 7,980 (K) |
| EPS | 0.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.17 |
| Profit Margin | 1.3 % |
| Operating Margin | 4 % |
| Return on Assets (ttm) | -0.1 % |
| Return on Equity (ttm) | 1.8 % |
| Qtrly Rev. Growth | 43 % |
| Gross Profit (p.s.) | 3.45 |
| Sales Per Share | 5.05 |
| EBITDA (p.s.) | 0.08 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 24 (M) |
| Levered Free Cash Flow | 12 (M) |
| PE Ratio | 31.38 |
| PEG Ratio | 0 |
| Price to Book value | 5.04 |
| Price to Sales | 4.15 |
| Price to Cash Flow | 54.36 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|